To date, only 28 COXPD21 patients and 28 pathogenic variants in TARS2 have been reported; thus, the genotype-phenotype relationships are not well established [1, 9–13]. The gene discussed is TARS2; the disease is Combined oxidative phosphorylation defect type 21.